Back to Archived Journals » Core Evidence » Volume 6

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma

Total article views   HTML views PDF downloads Totals
16,992 Dovepress* 11,936+ 4,746 16,682
PubMed Central* 5,056 1,454 6,510
Totals 16,992 6,200 23,192
*Since 4 April 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 1 4

View citations on PubMed Central and Google Scholar